Man fandt ud af, at tidlig indledning af behandling resulterede i en yderligere nedsat risiko for udvikling af hepatocellulært carcinom (13, 5 gange ved indledning inden 12 måneders alderen).
It was found that the early initiation of treatment resulted in a further reduced risk for the development of hepatocellular carcinoma (13.5-fold when initiated prior to the age of 12 months).